Geneos Wealth Management Inc. Astrazeneca PLC Transaction History
Geneos Wealth Management Inc.
- $2.6 Billion
- Q3 2024
A detailed history of Geneos Wealth Management Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 16,394 shares of AZN stock, worth $1.07 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
16,394
Previous 14,728
11.31%
Holding current value
$1.07 Million
Previous $1.15 Million
11.24%
% of portfolio
0.05%
Previous 0.05%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.12 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.75 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.41 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.25 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...